IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Crop Life Science IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Chemical - Pesticides sector. Interactive Financial Services is the merchant banker of Crop Life Science IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 20th April 2023.
Crop Life Science IPO posted revenues of Rs 123.23 crores and PAT of Rs 4.37 crores in FY25 on annualised basis.Financial results of Crop Life Science IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Crop Life Science IPO PAT Margin is 3.56%, ROCE (Return on Capital Employed) is 18.63% as per latest financial. The below table shows Crop Life Science IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Crop Life Science IPO is Rs 62.45 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Crop Life Science IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Crop Life Science IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Crop Life Science IPO is ₹62.45 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Crop Life Science IPO has a Price-to-Earnings (PE) ratio of 14.29 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Crop Life Science IPO reported revenue of ₹123.23 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Crop Life Science IPO provide insights into sales growth, market demand, and business scalability.
Crop Life Science recorded an EBITDA of ₹ 11.39 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Crop Life Science Profit After Tax (PAT) is ₹4.36 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 122.53 Cr.
EBITDA Margin:
9.30
%
Net Worth: ₹ 40.38 Cr.
Market Capitalisation:
₹ 62.45 Cr.
P/E:
14.29 times
P/BV: 0.93 times
EV/EBITDA: 7.72 times
Crop Life Science operates in Chemical - Pesticides and Manufacturing, Distributing, And Marketing Of Agro Chemical Formulations. The Issue is listed on NSE EMERGE in Aug, 2023. Crop Life Science IPO size was 26.73 with Issue price of 52.00 .
Merchant Banker(s) of Crop Life Science IPO: Interactive Financial Services Limited
Crop Life Science IPO subscription was 4.36 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Crop Life Science IPO listed at a listing price of 53.15 against the offer price of 52.00.
The current market price of Crop Life Science is 47.15.
Why Us?
